Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aschan

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Bone Marrow Transplantation|October 1, 1994
Treatment of moderate to severe acute graft-versus-host disease: a retrospective analysisJ Aschan
Clinical Transplantation|June 1, 1994
Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host diseaseJ Aschan, O Ringdén
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2001
The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapseS Carlens, M Remberger, J Aschan, et al.
European Journal of Haematology|August 1, 1992
A randomized trial comparing the use of fresh and stored platelets in the treatment of bone marrow transplant recipientsA Shanwell, S Larsson, J Aschan, et al.
Leukemia|December 26, 2001
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantationJ Mattsson, M Uzunel, L Tammik, et al.
Bone Marrow Transplantation|September 22, 1999
Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemiaS Carlens, J Aschan, M Remberger, et al.
Clinical Transplantation|June 8, 2001
Treatment of severe acute graft-versus-host disease with anti-thymocyte globulinM Remberger, J Aschan, L Barkholt, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1992
Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipientsJ Aschan, O Ringdén, P Ljungman, et al.
Bone Marrow Transplantation|August 29, 2007
Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCTG Avetisyan, J Aschan, H Hägglund, et al.
Bone Marrow Transplantation|August 6, 2003
N-acetyl-L-cysteine does not affect the pharmacokinetics or myelosuppressive effect of busulfan during conditioning prior to allogeneic stem cell transplantationF Sjöö, J Aschan, L Barkholt, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Bone Marrow Transplantation|October 1, 1994
Treatment of moderate to severe acute graft-versus-host disease: a retrospective analysisJ Aschan
Clinical Transplantation|June 1, 1994
Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host diseaseJ Aschan, O Ringdén
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2001
The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapseS Carlens, M Remberger, J Aschan, et al.
European Journal of Haematology|August 1, 1992
A randomized trial comparing the use of fresh and stored platelets in the treatment of bone marrow transplant recipientsA Shanwell, S Larsson, J Aschan, et al.
Leukemia|December 26, 2001
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantationJ Mattsson, M Uzunel, L Tammik, et al.
Bone Marrow Transplantation|September 22, 1999
Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemiaS Carlens, J Aschan, M Remberger, et al.
Clinical Transplantation|June 8, 2001
Treatment of severe acute graft-versus-host disease with anti-thymocyte globulinM Remberger, J Aschan, L Barkholt, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1992
Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipientsJ Aschan, O Ringdén, P Ljungman, et al.
Bone Marrow Transplantation|August 29, 2007
Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCTG Avetisyan, J Aschan, H Hägglund, et al.
Bone Marrow Transplantation|August 6, 2003
N-acetyl-L-cysteine does not affect the pharmacokinetics or myelosuppressive effect of busulfan during conditioning prior to allogeneic stem cell transplantationF Sjöö, J Aschan, L Barkholt, et al.
Pageof 7